Cargando…

Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients

Glioma is the most common and fatal primary brain tumor in humans. A significant role for long non-coding RNA (lncRNA) in glioma is the regulation of gene expression and chromatin recombination, and immunotherapy is a promising cancer treatment. Therefore, it is necessary to identify necroptosis-rel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Desheng, Dou, Chao, Liu, Haiyu, Xu, Binshun, Hu, Bowen, Kuang, Liangwen, Yao, Jiawei, Zhao, Yan, Yu, Shan, Li, Yang, Wang, Fuqing, Guo, Mian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402092/ https://www.ncbi.nlm.nih.gov/pubmed/36033536 http://dx.doi.org/10.3389/fonc.2022.929233

Ejemplares similares

New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis
por: Chen, Desheng, et al.
Publicado: (2022)

Comprehensive Characterization of Necroptosis-Related lncRNAs in Bladder Cancer Identifies a Novel Signature for Prognosis Prediction
por: XiaYu, Kuang, et al.
Publicado: (2022)

Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs
por: Wang, Guowei, et al.
Publicado: (2022)

Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022)

The Prediction of Necroptosis-Related lncRNAs in Prognosis and Anticancer Therapy of Colorectal Cancer
por: Xiao, Hanyu, et al.
Publicado: (2022)

Identification of hub necroptosis-related lncRNAs for prognosis prediction of esophageal carcinoma
por: Luo, Zhengdong, et al.
Publicado: (2023)

Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
por: Mo, Jiantao, et al.
Publicado: (2022)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Necroptosis-related lncRNAs: establishment of a gene module and distinction between the cold and hot tumors in glioma
por: Cao, Kangxi, et al.
Publicado: (2023)

Identification of cuproptosis‐related lncRNAs for prognosis and immunotherapy in glioma
por: Wang, Lin, et al.
Publicado: (2022)

M(7)G-related LncRNAs: A comprehensive analysis of the prognosis and immunity in glioma
por: Wu, Shuaishuai, et al.
Publicado: (2022)

Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
por: Zhao, Zirui, et al.
Publicado: (2021)

Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer
por: Xu, Yuhao, et al.
Publicado: (2022)

A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
por: Liu, Binfeng, et al.
Publicado: (2022)

Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma
por: Duan, Xiaoyang, et al.
Publicado: (2023)

Necroptosis-related LncRNAs in skin cutaneous melanoma: evaluating prognosis, predicting immunity, and guiding therapy
por: Liu, Jianlan, et al.
Publicado: (2023)

Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
por: Li, Sui, et al.
Publicado: (2022)

Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma
por: Hu, Chenggong, et al.
Publicado: (2018)

Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: Chen, Fei, et al.
Publicado: (2022)

Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs
por: Liu, Dongze, et al.
Publicado: (2022)

Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas
por: Yan, Yuanliang, et al.
Publicado: (2017)

LncRNAs in Stem Cells
por: Hu, Shanshan, et al.
Publicado: (2016)

Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer
por: Su, Xiaohui, et al.
Publicado: (2020)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
por: Liu, Chunhua, et al.
Publicado: (2023)

Functional implications of aging-related lncRNAs for predicting prognosis and immune status in glioma patients
por: Zhang, Guangying, et al.
Publicado: (2022)

Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma
por: Huang, Qianrong, et al.
Publicado: (2023)

Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs
por: Diao, Xiayao, et al.
Publicado: (2022)

Identification of Epithelial Mesenchymal Transition-Related lncRNAs Associated with Prognosis and Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022)

Pathological Grade-Associated Transcriptome Profiling of lncRNAs and mRNAs in Gliomas
por: Sun, Junlong, et al.
Publicado: (2020)

Decoding LncRNAs
por: Borkiewicz, Lidia, et al.
Publicado: (2021)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021)

Comprehensive analysis of metabolism-related lncRNAs related to the progression and prognosis in osteosarcoma from TCGA
por: Chen, Xingyin, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognosis and Drug Sensitivity of Differentiation-Related lncRNAs in Papillary Thyroid Cancer
por: Wang, Wenlong, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs in the prognosis and therapy response of patients with bladder cancer
por: Li, Ding, et al.
Publicado: (2022)

Comprehensive analysis of anoikis‐related lncRNAs for predicting prognosis and response of immunotherapy in hepatocellular carcinoma
por: Du, Sihao, et al.
Publicado: (2023)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
por: Zhu, Shusheng, et al.
Publicado: (2023)

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
por: Zhang, Jiheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_87ohre2g1db19lqii86qt3ge4k